Worth Venture Partners’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Worth Venture Partners’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,153,778	Closed	-$4.21M	–	130
2023 Q4	$4.21M	Buy	1,153,778 +1,500	+0.1%	+$4.11K	2.28%	11
2023 Q3	$2.56M	Buy	1,152,278 +50,598	+5%	+$141K	1.52%	15
2023 Q2	$3.75M	Buy	1,101,680 +216,878	+25%	+$782K	2.04%	14
2023 Q1	$3.53M	Hold	884,802	–	–	1.72%	13
2022 Q4	$4.81M	Sell	884,802 -26,435	-3%	-$156K	2.84%	6
2022 Q3	$4.58M	Buy	911,237 +286,424	+46%	+$1.41M	2.81%	8
2022 Q2	$2.74M	Buy	624,813 +15,643	+3%	+$99.9K	1.61%	18
2022 Q1	$4.31M	Buy	+609,170	New	+$4.28M	1.99%	14

Other funds holding TGAN

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Worth Venture Partners's TGAN Position: Q1 2024 in Review

Worth Venture Partners sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2024, closing a stake of 1,153,778 shares — an estimated $4.21M sold.

Worth Venture Partners first reported a position in TGAN in Q1 2022 and held it in 8 quarters. The position peaked at $4.81M in Q4 2022. 57 funds tracked by Wall St. Rank hold TGAN as of Q1 2024.

Worth Venture Partners reported no remaining Transphorm, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Worth Venture Partners sold 1,153,778 Transphorm, Inc. Common Stock shares in Q1 2024, an estimated $4.21M.
Worth Venture Partners first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
Worth Venture Partners's Transphorm, Inc. Common Stock position peaked at $4.81M in Q4 2022.
57 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.